Gail I. Marousek

Suggest Changes
Learn More
Interferon (IFN) and ribavirin combination therapy for chronic hepatitis C virus (HCV) infection yields a sustained response rate of only ∼40%. Previous studies have linked IFN responsiveness to(More)